A new University of Kent start-up has been launched to commercialize biotechnology that could make it cheaper and easier to produce proteins used in cancer treatments, vaccines and diagnostic tests. Sirius Proteins was registered this month, taking technology developed and patented at Kent a step closer to wider commercial use.

A new review by a team of researchers from Indonesia, Japan and China, led by Professor Nurhasni Hasan from the Faculty of Pharmacy at Hasanuddin University in Indonesia, examines how emerging local drug delivery systems could be designed to overcome barriers to treating oral squamous cell carcinoma (OSCC), which is one of the most common malignancies affecting the oral cavity and head and neck region and contributes significantly to the global burden of cancer-related morbidity and mortality.

Overuse of reliever inhalers is associated with higher risks of developing and dying from cardiovascular disease, including heart failure, heart attack and ischemic stroke, in patients with asthma and COPD, according to a study published today in ERJ Open Research.

Breast cancer is often classified as either estrogen receptor-positive (hormone-sensitive) or not. However, a new study from Karolinska Institutet suggests that this simplified classification may overlook important biological differences between patients that could affect treatment decisions. The results are published in The Lancet Regional Health – Europe.

Some people with epilepsy experience delusions, hallucinations, paranoia and confusion after a seizure. While these episodes usually last only days, a new study led by researchers at Carilion Clinic suggests they may place patients at significantly higher risk of developing psychiatric disorders later.